EMMC Receives Grant to Implement Pharmacy-Led Smoking Cessation Program
Eastern Maine Medical Center is pleased to announce the awarding of a grant to establish a new pharmacy-led smoking cessation program. The patient program is a joint effort by EMMC Cancer Care, Miller Drug, and Eastern Maine Medical Center Clinical Research.
The grant, awarded by Northern New England Clinical Oncology Society – or NNECOS – will help fund a study titled The Efficacy of a Pharmacist‐led Smoking Cessation Intervention for Oncology Patients and seeks to encourage smoking cessation. Matthew Marston, PharmD, a member of NNECOS and a certified tobacco cessation specialist, will provide administrative oversight of Miller Drug’s protocol and participate in counseling and treatment for oncology patients, while Antoine Harb, MD, hematologist and oncologist, Adult Oncology, and principal investigator, will provide valuable insights on the replicability of this protocol for other NNECOS members and oncology practices throughout the region.
“This is a wonderful opportunity for us to work collaboratively for the benefit of tobacco users near and far,” says Dr. Harb. “The information we will be able to gather through this study will help tremendously in encouraging smokers to kick the habit, and we look forward to sharing our findings with the larger NNECOS membership.”
During the grant period, March 2018 to March 2019, all patients 18 years or older at EMMC Cancer Care will be screened for smoking use and invited to participate in the study. Participants must identify as daily smokers and be motivated to quit smoking in the next 30 days